nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.0183	0.037	CcSEcCtD
Octreotide—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.0137	0.0276	CcSEcCtD
Octreotide—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.0115	0.0232	CcSEcCtD
Octreotide—Diabetic—Lisinopril—dilated cardiomyopathy	0.00827	0.0167	CcSEcCtD
Octreotide—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00797	0.0161	CcSEcCtD
Octreotide—Breast pain—Spironolactone—dilated cardiomyopathy	0.00775	0.0156	CcSEcCtD
Octreotide—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00772	0.0156	CcSEcCtD
Octreotide—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00769	0.0155	CcSEcCtD
Octreotide—Local reaction—Furosemide—dilated cardiomyopathy	0.00664	0.0134	CcSEcCtD
Octreotide—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00664	0.0134	CcSEcCtD
Octreotide—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00621	0.0125	CcSEcCtD
Octreotide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00605	0.0122	CcSEcCtD
Octreotide—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00555	0.0112	CcSEcCtD
Octreotide—Renal pain—Lisinopril—dilated cardiomyopathy	0.00525	0.0106	CcSEcCtD
Octreotide—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00511	0.0103	CcSEcCtD
Octreotide—Cholestasis—Furosemide—dilated cardiomyopathy	0.00484	0.00978	CcSEcCtD
Octreotide—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00458	0.00924	CcSEcCtD
Octreotide—Injection site pain—Furosemide—dilated cardiomyopathy	0.0045	0.0091	CcSEcCtD
Octreotide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00442	0.00892	CcSEcCtD
Octreotide—Gastritis—Spironolactone—dilated cardiomyopathy	0.00434	0.00877	CcSEcCtD
Octreotide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00419	0.00845	CcSEcCtD
Octreotide—Drug interaction—Furosemide—dilated cardiomyopathy	0.00396	0.00801	CcSEcCtD
Octreotide—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00386	0.0078	CcSEcCtD
Octreotide—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00386	0.0078	CcSEcCtD
Octreotide—Throat sore—Lisinopril—dilated cardiomyopathy	0.00383	0.00773	CcSEcCtD
Octreotide—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00379	0.00766	CcSEcCtD
Octreotide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00378	0.00764	CcSEcCtD
Octreotide—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00366	0.0074	CcSEcCtD
Octreotide—Otitis media—Lisinopril—dilated cardiomyopathy	0.00354	0.00716	CcSEcCtD
Octreotide—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00338	0.00682	CcSEcCtD
Octreotide—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00333	0.00672	CcSEcCtD
Octreotide—Bladder pain—Furosemide—dilated cardiomyopathy	0.00333	0.00672	CcSEcCtD
Octreotide—Urine output increased—Furosemide—dilated cardiomyopathy	0.00333	0.00672	CcSEcCtD
Octreotide—Breast pain—Lisinopril—dilated cardiomyopathy	0.00316	0.00639	CcSEcCtD
Octreotide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00314	0.00634	CcSEcCtD
Octreotide—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00308	0.00623	CcSEcCtD
Octreotide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00307	0.0062	CcSEcCtD
Octreotide—Viral infection—Lisinopril—dilated cardiomyopathy	0.00306	0.00617	CcSEcCtD
Octreotide—Polyuria—Furosemide—dilated cardiomyopathy	0.00304	0.00614	CcSEcCtD
Octreotide—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00303	0.00613	CcSEcCtD
Octreotide—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00303	0.00613	CcSEcCtD
Octreotide—Alopecia—Spironolactone—dilated cardiomyopathy	0.003	0.00606	CcSEcCtD
Octreotide—Deafness—Furosemide—dilated cardiomyopathy	0.00298	0.00603	CcSEcCtD
Octreotide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00297	0.00601	CcSEcCtD
Octreotide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00284	0.00574	CcSEcCtD
Octreotide—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00276	0.00557	CcSEcCtD
Octreotide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00274	0.00554	CcSEcCtD
Octreotide—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00271	0.00548	CcSEcCtD
Octreotide—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.0027	0.00544	CcSEcCtD
Octreotide—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00268	0.00541	CcSEcCtD
Octreotide—Wheezing—Lisinopril—dilated cardiomyopathy	0.00268	0.00541	CcSEcCtD
Octreotide—Malaise—Spironolactone—dilated cardiomyopathy	0.00266	0.00538	CcSEcCtD
Octreotide—Cystitis—Lisinopril—dilated cardiomyopathy	0.00266	0.00538	CcSEcCtD
Octreotide—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00259	0.00523	CcSEcCtD
Octreotide—Irritability—Furosemide—dilated cardiomyopathy	0.00255	0.00515	CcSEcCtD
Octreotide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00249	0.00504	CcSEcCtD
Octreotide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00249	0.00502	CcSEcCtD
Octreotide—Dehydration—Furosemide—dilated cardiomyopathy	0.00248	0.00501	CcSEcCtD
Octreotide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00241	0.00487	CcSEcCtD
Octreotide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0024	0.00485	CcSEcCtD
Octreotide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00236	0.00477	CcSEcCtD
Octreotide—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00235	0.00476	CcSEcCtD
Octreotide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00232	0.00469	CcSEcCtD
Octreotide—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00231	0.00467	CcSEcCtD
Octreotide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.0023	0.00465	CcSEcCtD
Octreotide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00226	0.00457	CcSEcCtD
Octreotide—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00226	0.00456	CcSEcCtD
Octreotide—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0022	0.00444	CcSEcCtD
Octreotide—Injury—Lisinopril—dilated cardiomyopathy	0.00218	0.0044	CcSEcCtD
Octreotide—Somnolence—Spironolactone—dilated cardiomyopathy	0.00214	0.00433	CcSEcCtD
Octreotide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00213	0.0043	CcSEcCtD
Octreotide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00208	0.0042	CcSEcCtD
Octreotide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00208	0.0042	CcSEcCtD
Octreotide—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00207	0.00418	CcSEcCtD
Octreotide—Arthritis—Lisinopril—dilated cardiomyopathy	0.00206	0.00416	CcSEcCtD
Octreotide—Drowsiness—Furosemide—dilated cardiomyopathy	0.00206	0.00415	CcSEcCtD
Octreotide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00205	0.00415	CcSEcCtD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00201	0.00398	CbGpPWpGaD
Octreotide—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.002	0.00405	CcSEcCtD
Octreotide—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.002	0.00405	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.002	0.00396	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.002	0.00395	CbGpPWpGaD
Octreotide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00199	0.00401	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00198	0.00393	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00198	0.00393	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00196	0.00388	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00195	0.00393	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00194	0.00383	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00193	0.00382	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00193	0.00382	CbGpPWpGaD
Octreotide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00192	0.00387	CcSEcCtD
Octreotide—Irritability—Lisinopril—dilated cardiomyopathy	0.00191	0.00386	CcSEcCtD
Octreotide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00191	0.00385	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00189	0.00374	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00188	0.00372	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00187	0.0037	CbGpPWpGaD
Octreotide—Dehydration—Lisinopril—dilated cardiomyopathy	0.00186	0.00376	CcSEcCtD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00186	0.00368	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00185	0.00366	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00184	0.00365	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00182	0.0036	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00181	0.00359	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00181	0.00358	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00181	0.00358	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00181	0.00358	CbGpPWpGaD
Octreotide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.0018	0.00364	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0018	0.00356	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0018	0.00356	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00179	0.00355	CbGpPWpGaD
Octreotide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00179	0.00362	CcSEcCtD
Octreotide—Visual impairment—Furosemide—dilated cardiomyopathy	0.00178	0.00359	CcSEcCtD
Octreotide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00178	0.00359	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00178	0.00352	CbGpPWpGaD
Octreotide—Gastritis—Lisinopril—dilated cardiomyopathy	0.00177	0.00358	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00174	0.00344	CbGpPWpGaD
Octreotide—Influenza—Lisinopril—dilated cardiomyopathy	0.00173	0.0035	CcSEcCtD
Octreotide—Asthma—Lisinopril—dilated cardiomyopathy	0.00173	0.0035	CcSEcCtD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00173	0.00343	CbGpPWpGaD
Octreotide—Tinnitus—Furosemide—dilated cardiomyopathy	0.00172	0.00348	CcSEcCtD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00171	0.00339	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00171	0.00339	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00171	0.00339	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00171	0.00339	CbGpPWpGaD
Octreotide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00171	0.00345	CcSEcCtD
Octreotide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0017	0.00344	CcSEcCtD
Octreotide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.0017	0.00343	CcSEcCtD
Octreotide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00169	0.00341	CcSEcCtD
Octreotide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00167	0.00337	CcSEcCtD
Octreotide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00167	0.00336	CcSEcCtD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00166	0.00329	CbGpPWpGaD
Octreotide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00165	0.00333	CcSEcCtD
Octreotide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00165	0.00333	CcSEcCtD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00164	0.00325	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00162	0.00321	CbGpPWpGaD
Octreotide—Dysuria—Lisinopril—dilated cardiomyopathy	0.00162	0.00327	CcSEcCtD
Octreotide—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00161	0.00325	CcSEcCtD
Octreotide—Malnutrition—Furosemide—dilated cardiomyopathy	0.00161	0.00325	CcSEcCtD
Octreotide—Erythema—Furosemide—dilated cardiomyopathy	0.00161	0.00325	CcSEcCtD
Octreotide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00159	0.00322	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00159	0.00315	CbGpPWpGaD
Octreotide—Flatulence—Furosemide—dilated cardiomyopathy	0.00158	0.0032	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00158	0.00313	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00158	0.00313	CbGpPWpGaD
Octreotide—Weight increased—Lisinopril—dilated cardiomyopathy	0.00158	0.00318	CcSEcCtD
Octreotide—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00157	0.00316	CcSEcCtD
Octreotide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00156	0.00315	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00156	0.00308	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00155	0.00308	CbGpPWpGaD
Octreotide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00155	0.00314	CcSEcCtD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00155	0.00306	CbGpPWpGaD
Octreotide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00155	0.00312	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00154	0.00305	CbGpPWpGaD
Octreotide—Depression—Lisinopril—dilated cardiomyopathy	0.00154	0.00311	CcSEcCtD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00153	0.00304	CbGpPWpGaD
Octreotide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00153	0.0031	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00153	0.00303	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00153	0.00303	CbGpPWpGaD
Octreotide—Rash—Spironolactone—dilated cardiomyopathy	0.00152	0.00307	CcSEcCtD
Octreotide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00152	0.00307	CcSEcCtD
Octreotide—Vision blurred—Furosemide—dilated cardiomyopathy	0.00152	0.00306	CcSEcCtD
Octreotide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00151	0.00306	CcSEcCtD
Octreotide—Headache—Spironolactone—dilated cardiomyopathy	0.00151	0.00305	CcSEcCtD
Octreotide—Jaundice—Lisinopril—dilated cardiomyopathy	0.0015	0.00304	CcSEcCtD
Octreotide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.0015	0.00303	CcSEcCtD
Octreotide—Anaemia—Furosemide—dilated cardiomyopathy	0.00149	0.003	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00148	0.00294	CbGpPWpGaD
Octreotide—Agitation—Furosemide—dilated cardiomyopathy	0.00148	0.00298	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00147	0.00292	CbGpPWpGaD
Octreotide—Haematuria—Lisinopril—dilated cardiomyopathy	0.00147	0.00297	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00147	0.00291	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00147	0.00291	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00147	0.00291	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00147	0.00291	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00146	0.00295	CcSEcCtD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00146	0.00288	CbGpPWpGaD
Octreotide—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00146	0.00294	CcSEcCtD
Octreotide—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00145	0.00292	CcSEcCtD
Octreotide—Vertigo—Furosemide—dilated cardiomyopathy	0.00144	0.00292	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00144	0.00284	CbGpPWpGaD
Octreotide—Nausea—Spironolactone—dilated cardiomyopathy	0.00143	0.00289	CcSEcCtD
Octreotide—MPO—IL23-mediated signaling events—TNF—dilated cardiomyopathy	0.00143	0.00283	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00142	0.00282	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00142	0.00281	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00142	0.00281	CbGpPWpGaD
Octreotide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00141	0.00285	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00141	0.00279	CbGpPWpGaD
Octreotide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00139	0.00281	CcSEcCtD
Octreotide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00139	0.0028	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00138	0.00273	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00138	0.00273	CbGpPWpGaD
Octreotide—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00138	0.00278	CcSEcCtD
Octreotide—SSTR3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00137	0.00271	CbGpPWpGaD
Octreotide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00137	0.00276	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00137	0.0027	CbGpPWpGaD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00136	0.00275	CcSEcCtD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00134	0.00266	CbGpPWpGaD
Octreotide—Dry mouth—Furosemide—dilated cardiomyopathy	0.00134	0.0027	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00132	0.00262	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00131	0.0026	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00131	0.0026	CbGpPWpGaD
Octreotide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00131	0.00265	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0013	0.00258	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0013	0.00258	CbGpPWpGaD
Octreotide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00129	0.00261	CcSEcCtD
Octreotide—Shock—Furosemide—dilated cardiomyopathy	0.00129	0.00261	CcSEcCtD
Octreotide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00129	0.0026	CcSEcCtD
Octreotide—Flushing—Lisinopril—dilated cardiomyopathy	0.00129	0.0026	CcSEcCtD
Octreotide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00128	0.00259	CcSEcCtD
Octreotide—Skin disorder—Furosemide—dilated cardiomyopathy	0.00127	0.00257	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00127	0.00252	CbGpPWpGaD
Octreotide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00127	0.00256	CcSEcCtD
Octreotide—Anorexia—Furosemide—dilated cardiomyopathy	0.00125	0.00253	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00125	0.00247	CbGpPWpGaD
Octreotide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00124	0.0025	CcSEcCtD
Octreotide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00122	0.00247	CcSEcCtD
Octreotide—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00121	0.00245	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00121	0.0024	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00121	0.0024	CbGpPWpGaD
Octreotide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00121	0.00244	CcSEcCtD
Octreotide—Erythema—Lisinopril—dilated cardiomyopathy	0.00121	0.00244	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0012	0.00238	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0012	0.00238	CbGpPWpGaD
Octreotide—Flatulence—Lisinopril—dilated cardiomyopathy	0.00119	0.0024	CcSEcCtD
Octreotide—Tension—Lisinopril—dilated cardiomyopathy	0.00118	0.00239	CcSEcCtD
Octreotide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00118	0.00238	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00118	0.00233	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00117	0.00232	CbGpPWpGaD
Octreotide—Nervousness—Lisinopril—dilated cardiomyopathy	0.00117	0.00237	CcSEcCtD
Octreotide—Back pain—Lisinopril—dilated cardiomyopathy	0.00117	0.00236	CcSEcCtD
Octreotide—Somnolence—Furosemide—dilated cardiomyopathy	0.00117	0.00236	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00116	0.00231	CbGpPWpGaD
Octreotide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00116	0.00234	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00115	0.00228	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00114	0.00226	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00114	0.00226	CbGpPWpGaD
Octreotide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00114	0.0023	CcSEcCtD
Octreotide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00114	0.0023	CcSEcCtD
Octreotide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00113	0.00229	CcSEcCtD
Octreotide—Fatigue—Furosemide—dilated cardiomyopathy	0.00113	0.00228	CcSEcCtD
Octreotide—Tremor—Lisinopril—dilated cardiomyopathy	0.00113	0.00228	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00113	0.00224	CbGpPWpGaD
Octreotide—Constipation—Furosemide—dilated cardiomyopathy	0.00112	0.00227	CcSEcCtD
Octreotide—Pain—Furosemide—dilated cardiomyopathy	0.00112	0.00227	CcSEcCtD
Octreotide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00112	0.00226	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00112	0.00221	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00112	0.00221	CbGpPWpGaD
Octreotide—Anaemia—Lisinopril—dilated cardiomyopathy	0.00111	0.00225	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00111	0.00219	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00109	0.00217	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00109	0.00216	CbGpPWpGaD
Octreotide—Malaise—Lisinopril—dilated cardiomyopathy	0.00109	0.0022	CcSEcCtD
Octreotide—Vertigo—Lisinopril—dilated cardiomyopathy	0.00108	0.00219	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00108	0.00214	CbGpPWpGaD
Octreotide—Syncope—Lisinopril—dilated cardiomyopathy	0.00108	0.00218	CcSEcCtD
Octreotide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00108	0.00218	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00107	0.00213	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00107	0.00217	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00107	0.00212	CbGpPWpGaD
Octreotide—Palpitations—Lisinopril—dilated cardiomyopathy	0.00107	0.00215	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00106	0.0021	CbGpPWpGaD
Octreotide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00106	0.00214	CcSEcCtD
Octreotide—Cough—Lisinopril—dilated cardiomyopathy	0.00105	0.00213	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00104	0.00207	CbGpPWpGaD
Octreotide—Urticaria—Furosemide—dilated cardiomyopathy	0.00104	0.00211	CcSEcCtD
Octreotide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00104	0.00209	CcSEcCtD
Octreotide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00104	0.00209	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00104	0.00205	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00104	0.00205	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00103	0.00204	CbGpPWpGaD
Octreotide—Chest pain—Lisinopril—dilated cardiomyopathy	0.00103	0.00207	CcSEcCtD
Octreotide—Myalgia—Lisinopril—dilated cardiomyopathy	0.00103	0.00207	CcSEcCtD
Octreotide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00103	0.00207	CcSEcCtD
Octreotide—Anxiety—Lisinopril—dilated cardiomyopathy	0.00102	0.00207	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00102	0.00206	CcSEcCtD
Octreotide—Discomfort—Lisinopril—dilated cardiomyopathy	0.00101	0.00205	CcSEcCtD
Octreotide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.001	0.00203	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.001	0.00198	CbGpPWpGaD
Octreotide—Oedema—Lisinopril—dilated cardiomyopathy	0.000985	0.00199	CcSEcCtD
Octreotide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000985	0.00199	CcSEcCtD
Octreotide—Infection—Lisinopril—dilated cardiomyopathy	0.000978	0.00198	CcSEcCtD
Octreotide—Shock—Lisinopril—dilated cardiomyopathy	0.000969	0.00196	CcSEcCtD
Octreotide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000967	0.00195	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000964	0.00191	CbGpPWpGaD
Octreotide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000964	0.00195	CcSEcCtD
Octreotide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000961	0.00194	CcSEcCtD
Octreotide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000956	0.00193	CcSEcCtD
Octreotide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000952	0.00192	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00095	0.00188	CbGpPWpGaD
Octreotide—Asthenia—Furosemide—dilated cardiomyopathy	0.000941	0.0019	CcSEcCtD
Octreotide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000938	0.0019	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000934	0.00185	CbGpPWpGaD
Octreotide—Pruritus—Furosemide—dilated cardiomyopathy	0.000928	0.00187	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000925	0.00183	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000924	0.00183	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.0009	0.00178	CbGpPWpGaD
Octreotide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000898	0.00181	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000897	0.00181	CcSEcCtD
Octreotide—Insomnia—Lisinopril—dilated cardiomyopathy	0.00089	0.0018	CcSEcCtD
Octreotide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000884	0.00179	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000878	0.00174	CbGpPWpGaD
Octreotide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000878	0.00177	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000877	0.00174	CbGpPWpGaD
Octreotide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000875	0.00177	CcSEcCtD
Octreotide—Dizziness—Furosemide—dilated cardiomyopathy	0.000868	0.00175	CcSEcCtD
Octreotide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000867	0.00175	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000865	0.00171	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000865	0.00171	CbGpPWpGaD
Octreotide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000856	0.00173	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000854	0.00169	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00085	0.00172	CcSEcCtD
Octreotide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000849	0.00171	CcSEcCtD
Octreotide—Constipation—Lisinopril—dilated cardiomyopathy	0.000842	0.0017	CcSEcCtD
Octreotide—Pain—Lisinopril—dilated cardiomyopathy	0.000842	0.0017	CcSEcCtD
Octreotide—Vomiting—Furosemide—dilated cardiomyopathy	0.000834	0.00168	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000833	0.00165	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00083	0.00164	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00083	0.00164	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000829	0.00164	CbGpPWpGaD
Octreotide—Rash—Furosemide—dilated cardiomyopathy	0.000827	0.00167	CcSEcCtD
Octreotide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000827	0.00167	CcSEcCtD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000825	0.00164	CbGpPWpGaD
Octreotide—Headache—Furosemide—dilated cardiomyopathy	0.000822	0.00166	CcSEcCtD
Octreotide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000811	0.00164	CcSEcCtD
Octreotide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000805	0.00163	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000805	0.00159	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000797	0.00158	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000795	0.00157	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000786	0.00156	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000786	0.00156	CbGpPWpGaD
Octreotide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000782	0.00158	CcSEcCtD
Octreotide—Nausea—Furosemide—dilated cardiomyopathy	0.000779	0.00157	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000779	0.00154	CbGpPWpGaD
Octreotide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000778	0.00157	CcSEcCtD
Octreotide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000778	0.00157	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000771	0.00153	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000757	0.0015	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000754	0.00149	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000754	0.00149	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000747	0.00148	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000736	0.00146	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000736	0.00146	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000731	0.00145	CbGpPWpGaD
Octreotide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000725	0.00146	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000715	0.00142	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000708	0.0014	CbGpPWpGaD
Octreotide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000706	0.00143	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000705	0.0014	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000701	0.00139	CbGpPWpGaD
Octreotide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000697	0.00141	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00069	0.00137	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000684	0.00136	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000679	0.00135	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000679	0.00135	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000678	0.00134	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000676	0.00134	CbGpPWpGaD
Octreotide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000674	0.00136	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000668	0.00132	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000668	0.00132	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000666	0.00132	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000663	0.00131	CbGpPWpGaD
Octreotide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000651	0.00131	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00065	0.00129	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000647	0.00128	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000638	0.00126	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000631	0.00125	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000631	0.00125	CbGpPWpGaD
Octreotide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000626	0.00126	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000621	0.00123	CbGpPWpGaD
Octreotide—Rash—Lisinopril—dilated cardiomyopathy	0.000621	0.00125	CcSEcCtD
Octreotide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00062	0.00125	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000618	0.00122	CbGpPWpGaD
Octreotide—Headache—Lisinopril—dilated cardiomyopathy	0.000617	0.00125	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000617	0.00122	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000617	0.00122	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000613	0.00121	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000613	0.00121	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000611	0.00121	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000605	0.0012	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000604	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000602	0.00119	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000587	0.00116	CbGpPWpGaD
Octreotide—Nausea—Lisinopril—dilated cardiomyopathy	0.000585	0.00118	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000579	0.00115	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000573	0.00114	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000573	0.00114	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00057	0.00113	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000566	0.00112	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000561	0.00111	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000555	0.0011	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000552	0.00109	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00055	0.00109	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000537	0.00106	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000523	0.00104	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000522	0.00103	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000514	0.00102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000501	0.000993	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000495	0.000981	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00049	0.000971	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000488	0.000966	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000474	0.000939	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000471	0.000933	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00047	0.000931	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000468	0.000928	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000464	0.00092	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000464	0.00092	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00045	0.000891	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000449	0.000889	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000447	0.000885	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000445	0.000882	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000445	0.000882	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000445	0.000882	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000445	0.000881	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000432	0.000855	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000427	0.000845	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000425	0.000842	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000418	0.000828	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000417	0.000826	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000414	0.00082	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00041	0.000813	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000408	0.000808	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000401	0.000794	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000398	0.000789	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000395	0.000782	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000395	0.000782	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000389	0.000771	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000385	0.000762	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000384	0.000761	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000378	0.00075	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000367	0.000728	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000367	0.000727	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000364	0.000722	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000364	0.000722	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000362	0.000716	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000357	0.000707	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000355	0.000704	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000349	0.000692	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000347	0.000687	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000342	0.000678	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000339	0.000671	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000339	0.000671	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000334	0.000661	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000332	0.000657	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000328	0.00065	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000325	0.000643	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000304	0.000601	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000295	0.000585	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000291	0.000577	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000288	0.00057	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000283	0.000561	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00028	0.000555	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000279	0.000553	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000267	0.000529	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000266	0.000526	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000263	0.000521	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000252	0.000499	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000251	0.000498	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000251	0.000497	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000247	0.00049	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000241	0.000477	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000232	0.000459	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00023	0.000456	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000228	0.000452	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000224	0.000443	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000214	0.000423	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000206	0.000409	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000202	0.000401	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000197	0.000391	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000194	0.000384	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000174	0.000345	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000172	0.000341	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000167	0.000331	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000159	0.000315	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000158	0.000313	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000148	0.000294	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000137	0.000271	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00012	0.000237	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000115	0.000227	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000102	0.000201	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.38e-05	0.000186	CbGpPWpGaD
